washington semaglutide & tirzepatide vs Tirzepatide: Which GLP-1 Wins for Weight Loss? A lot of our patients

After all, when weighed against the most severe consequences of obesity, long-term effects dont matter much if youre dead

Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects

This makes it a safer and more promising option for long-term studies (5)

A Combined Approach: GLP-1 Agonists and Bariatric Surgery One exciting area of research and practice is the combination therapy involving both GLP-1 agonists and bariatric surgery, either preoperatively or postoperatively

Why do some individuals not respond to GLP-1 medications

The three-year study of 1,032 adults showed that weekly injections of tirzepatide cut the risk of developing Type 2 diabetes by 94% in prediabetic adults who were overweight or obese, compared to placebo